{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"20.49","upperLimit":"93.79","value":"57.14"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"}],"units":"Participants"}],"description":"E2FS (from time of first event) will be calculated to describe the outcome for patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy.","dispersionType":"95% Confidence Interval","groups":[{"description":"All eligible patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy","id":"OG000","title":"All Patients"}],"paramType":"NUMBER","populationDescription":"Eligible patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy","reportingStatus":"POSTED","timeFrame":"From the time of the first progressive, non-metastatic event until the subsequent occurrence of relapse, progressive disease, secondary malignancy, or death; up to 3 years","title":"Second-event-free Survival (E2FS)","type":"SECONDARY","unitOfMeasure":"Percentage"}